If you’ve ever experienced lower back pain — and it’s hardly a rare occurrence, especially as people age — you’re well aware of its debilitating effects, both in terms of the pain itself and for its effects other movement you might try to make over the course of the day. There’s another concern for researchers working on pain relief these days: trying to avoid the use of opioids, which could worsen an existing crisis.
That’s what makes a recent piece of news from Persica Pharmaceuticals sound especially encouraging. The company recently announced the results of a clinical trial for PP353, a non-opioid treatment for chronic lower back pain. PP353 is designed to address a specific type of back pain: chronic pain as a result in what Persica Pharmaceuticals describes as “a chronic indolent…